Cybin taps Thermo Fisher for U.S. manufacturing of CYB003

2 months ago 5

• Healthcare

Solskin

• Cybin (NYSE:CYBN) said on Thursday that it has engaged Thermo Fisher Scientific (NYSE:TMO) to provide late clinical supply and potential U.S. commercial manufacturing of CYB003, its deuterated psilocin program
• Thermo Fisher will assist in Phase 3 development for the expanded

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. Cybin taps Thermo Fisher for U.S. manufacturing of CYB003